Teva Historical Financial Ratios

TEVA Stock  USD 15.08  0.41  2.65%   
Teva Pharma is promptly reporting on over 113 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Book Value Per Share of 8.38, Free Cash Flow Yield of 0.0374, Invested Capital of 0.0 or Operating Cash Flow Per Share of 1.64 will help investors to properly organize and evaluate Teva Pharma Industries financial condition quickly.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Teva Pharma Industries. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

About Teva Financial Ratios Analysis

Teva Pharma IndustriesFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Teva Pharma investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Teva financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Teva Pharma history.

Teva Pharma Financial Ratios Chart

At present, Teva Pharma's Days Sales Outstanding is projected to decrease significantly based on the last few years of reporting. The current year's Book Value Per Share is expected to grow to 8.38, whereas Price To Sales Ratio is forecasted to decline to 1.45.
Add Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Shareholders Equity Per ShareDebt To Equity
Capex Per ShareGraham Net Net
Average ReceivablesRevenue Per Share
Interest Debt Per ShareDebt To Assets
Enterprise Value Over E B I T D AGraham Number
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Teva Pharma Industries stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Teva Pharma sales, a figure that is much harder to manipulate than other Teva Pharma Industries multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Dividend Yield

Dividend Yield is Teva Pharma Industries dividend as a percentage of Teva Pharma stock price. Teva Pharma Industries dividend yield is a measure of Teva Pharma stock productivity, which can be interpreted as interest rate earned on an Teva Pharma investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.

Ptb Ratio

Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.
Most ratios from Teva Pharma's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Teva Pharma Industries current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Teva Pharma Industries. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
At present, Teva Pharma's Days Sales Outstanding is projected to decrease significantly based on the last few years of reporting. The current year's Book Value Per Share is expected to grow to 8.38, whereas Price To Sales Ratio is forecasted to decline to 1.45.
 2024 2025 (projected)
Dividend Yield0.0043380.004121
Price To Sales Ratio1.531.45

Teva Pharma fundamentals Correlations

-0.231.00.5-0.39-0.5-0.320.871.01.0-0.290.220.040.07-0.05-0.280.56-0.341.00.05-0.050.96-1.00.27-0.090.27
-0.23-0.250.120.690.670.67-0.03-0.25-0.230.65-0.36-0.19-0.380.230.080.26-0.06-0.25-0.120.5-0.350.2-0.070.44-0.28
1.0-0.250.49-0.42-0.52-0.350.861.01.0-0.320.20.060.06-0.08-0.270.54-0.351.00.03-0.070.97-0.990.27-0.10.25
0.50.120.490.05-0.1-0.030.480.490.50.0-0.01-0.25-0.080.110.050.23-0.380.50.020.230.43-0.50.050.340.11
-0.390.69-0.420.050.620.94-0.07-0.42-0.390.930.23-0.480.260.5-0.030.20.37-0.420.480.63-0.560.360.010.620.29
-0.50.67-0.52-0.10.620.64-0.35-0.52-0.50.63-0.38-0.28-0.310.310.280.060.13-0.53-0.130.37-0.630.44-0.270.24-0.31
-0.320.67-0.35-0.030.940.640.03-0.35-0.330.990.24-0.410.260.44-0.210.350.44-0.360.520.49-0.50.30.190.40.26
0.87-0.030.860.48-0.07-0.350.030.860.860.040.43-0.230.30.26-0.540.82-0.280.850.410.090.79-0.870.530.00.47
1.0-0.251.00.49-0.42-0.52-0.350.861.0-0.320.20.060.06-0.08-0.270.54-0.351.00.03-0.070.97-0.990.27-0.10.25
1.0-0.231.00.5-0.39-0.5-0.330.861.0-0.30.210.040.06-0.06-0.260.55-0.351.00.04-0.050.96-1.00.26-0.080.26
-0.290.65-0.320.00.930.630.990.04-0.32-0.30.25-0.380.260.4-0.190.320.48-0.330.520.51-0.480.270.170.430.26
0.22-0.360.2-0.010.23-0.380.240.430.20.210.25-0.390.980.41-0.620.340.230.20.890.170.17-0.190.570.190.97
0.04-0.190.06-0.25-0.48-0.28-0.41-0.230.060.04-0.38-0.39-0.42-0.960.29-0.410.030.06-0.48-0.220.1-0.01-0.31-0.24-0.5
0.07-0.380.06-0.080.26-0.310.260.30.060.060.260.98-0.420.43-0.570.250.270.060.890.20.04-0.050.520.220.94
-0.050.23-0.080.110.50.310.440.26-0.08-0.060.40.41-0.960.43-0.280.47-0.05-0.080.520.22-0.120.010.260.240.51
-0.280.08-0.270.05-0.030.28-0.21-0.54-0.27-0.26-0.19-0.620.29-0.57-0.28-0.57-0.04-0.26-0.580.03-0.230.26-0.980.19-0.51
0.560.260.540.230.20.060.350.820.540.550.320.34-0.410.250.47-0.57-0.210.530.410.150.49-0.580.55-0.070.38
-0.34-0.06-0.35-0.380.370.130.44-0.28-0.35-0.350.480.230.030.27-0.05-0.04-0.21-0.350.340.0-0.40.35-0.020.00.14
1.0-0.251.00.5-0.42-0.53-0.360.851.01.0-0.330.20.060.06-0.08-0.260.53-0.350.03-0.070.97-0.990.27-0.10.25
0.05-0.120.030.020.48-0.130.520.410.030.040.520.89-0.480.890.52-0.580.410.340.030.21-0.05-0.030.530.210.85
-0.050.5-0.070.230.630.370.490.09-0.07-0.050.510.17-0.220.20.220.030.150.0-0.070.21-0.160.03-0.080.890.25
0.96-0.350.970.43-0.56-0.63-0.50.790.970.96-0.480.170.10.04-0.12-0.230.49-0.40.97-0.05-0.16-0.950.23-0.190.21
-1.00.2-0.99-0.50.360.440.3-0.87-0.99-1.00.27-0.19-0.01-0.050.010.26-0.580.35-0.99-0.030.03-0.95-0.260.08-0.25
0.27-0.070.270.050.01-0.270.190.530.270.260.170.57-0.310.520.26-0.980.55-0.020.270.53-0.080.23-0.26-0.220.47
-0.090.44-0.10.340.620.240.40.0-0.1-0.080.430.19-0.240.220.240.19-0.070.0-0.10.210.89-0.190.08-0.220.29
0.27-0.280.250.110.29-0.310.260.470.250.260.260.97-0.50.940.51-0.510.380.140.250.850.250.21-0.250.470.29
Click cells to compare fundamentals

Teva Pharma Account Relationship Matchups

Teva Pharma fundamentals Accounts

202020212022202320242025 (projected)
Price To Sales Ratio0.620.60.670.751.531.45
Days Sales Outstanding100.38104.1190.3978.567.49130.87
Book Value Per Share10.110.27.837.275.058.38
Free Cash Flow Yield0.06130.02470.10.07120.02960.0374
Operating Cash Flow Per Share1.110.721.431.221.11.64
Stock Based Compensation To Revenue0.0077440.0074950.0083080.0076360.0074350.004562
Capex To Depreciation0.290.370.420.460.470.45
Ev To Sales2.081.941.931.812.422.3
Free Cash Flow Per Share0.580.210.940.750.661.22
Roic(0.0843)0.0305(0.0478)0.013(0.0163)(0.0155)
Net Income Per Share(3.64)0.38(2.12)(0.5)(1.45)(1.37)
Days Of Inventory On Hand179.91168.22175.94178.98129.41143.34
Payables Turnover5.094.914.213.153.852.81
Sales General And Administrative To Revenue0.07040.06920.07910.07330.07020.0511
Research And Ddevelopement To Revenue0.05990.06090.05610.06580.06030.0517
Capex To Revenue0.03470.03540.03670.03320.03010.0286
Cash Per Share1.991.962.522.892.913.06
Pocfratio8.5611.986.318.6520.2826.0
Interest Coverage(3.71)1.62(2.17)0.42(0.3)(0.29)
Capex To Operating Cash Flow0.480.70.340.380.40.42
Pfcf Ratio16.3140.59.6214.0533.7632.07
Days Payables Outstanding71.7574.2986.61115.8294.81136.55
Income Quality(0.3)1.75(0.66)(2.45)(0.64)(0.6)
Roe(0.4)0.0406(0.3)(0.0745)(0.31)(0.29)
Ev To Operating Cash Flow28.4738.6618.1121.0232.1331.26
Pe Ratio(2.61)22.92(4.26)(21.16)(15.43)(14.66)
Return On Tangible Assets(0.19)0.0207(0.12)(0.0267)(0.0829)(0.0788)
Ev To Free Cash Flow54.27130.7327.6334.1553.4950.82
Earnings Yield(0.38)0.0436(0.23)(0.0473)(0.0648)(0.0616)
Net Debt To E B I T D A(12.43)4.83(20.28)10.8619.0219.97
Current Ratio0.980.991.141.051.021.67
Tangible Book Value Per Share(16.88)(14.76)(13.7)(12.91)(12.22)(11.61)
Receivables Turnover3.643.514.044.655.415.68
Shareholders Equity Per Share9.169.337.116.714.748.18

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Teva Pharma Industries offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Teva Pharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Teva Pharma Industries Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Teva Pharma Industries Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Teva Pharma Industries. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Teva Pharma. If investors know Teva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Teva Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.4
Earnings Share
(1.45)
Revenue Per Share
14.628
Quarterly Revenue Growth
(0.05)
Return On Assets
0.0509
The market value of Teva Pharma Industries is measured differently than its book value, which is the value of Teva that is recorded on the company's balance sheet. Investors also form their own opinion of Teva Pharma's value that differs from its market value or its book value, called intrinsic value, which is Teva Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Teva Pharma's market value can be influenced by many factors that don't directly affect Teva Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Teva Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Teva Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Teva Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.